Opioid players down premarket on start of Ohio trial

  • Teva Pharmaceutical Industries (NYSE:TEVA) (-4%), Endo International (NASDAQ:ENDP) (-11%) and Cardinal Health (NYSE:CAH) (-3%) are under modest pressure premarket ahead of the start of an opioid epidemic-related trial in Cleveland, OH. Two counties are suing certain companies over their role in the crisis there.
  • Update: Mallinckrodt (NYSE:MNK) is down 6% premarket and McKesson (NYSE:MCK) is down 4%. Medical products distributor Henry Schein (NASDAQ:HSIC) has been dismissed from the lawsuit.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.